---
schema_version: "secwatch.filing_event.v1"
accession: "0001651308-24-000154"
form_type: "8-K"
ticker: "ONC"
cik: "0001651308"
company_name: "BeOne Medicines Ltd."
filed_at: "2024-11-14T23:59:59+00:00"
generated_at: "2026-05-30T00:29:58.022746+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# BeiGene plans to change name to BeOne Medicines Ltd.; ticker to become ONC

## Summary
- Name change to BeOne Medicines Ltd. subject to shareholder approval at a future meeting.
- Nasdaq ticker symbol will change to 'ONC' upon completion of the name change.
- Rebranding reflects commitment to develop innovative cancer medicines through global partnerships.
- Shareholders urged to read definitive proxy statement when filed with the SEC.

## SEC filing metadata
- accession: 0001651308-24-000154
- form_type: 8-K
- ticker: ONC
- cik: 0001651308
- company_name: BeOne Medicines Ltd.
- filed_at: 2024-11-14T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1651308/000165130824000154/0001651308-24-000154-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1651308/000165130824000154/bgne-20241114.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001651308-24-000154
- JSON: https://secwatch.observer/filing/0001651308-24-000154.json
- Plain text: https://secwatch.observer/filing/0001651308-24-000154.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.